Pharma Retatrutide Injection, Brand Name : RETATRIRUDE

₹ 1,999 - ₹ 2,000 / Box

MOQ100 Gram
MaterialInjection
GradePharmaceutical Grade
Purity99.99%, 99
Brand NameRETATRIRUDE
Supply TypeManufacturer, Exporter, Supplier, Retailer, Distributor, Importer, Trader
Preferred Buyer Location All over the world

Company Information

Ask for more detail from the seller

Report incorrect details

Product Description

Mechanism of Action: Retatrutide is a first-in-class, single-peptide triple-receptor agonist. It mimics the action of three naturally occurring gut hormones simultaneously:
- GLP-1 (Glucagon-like peptide-1): Reduces appetite, slows digestion, and helps you feel fuller for longer.
- GIP (Glucose-dependent insulinotropic polypeptide): Enhances insulin secretion after eating and supports fat metabolism.
- Glucagon: Increases the body's energy expenditure and promotes the burning of stored fat for energy.
Form and Administration: It is a synthetic peptide administered as a once-weekly subcutaneous injection.
Target Conditions: It is currently in Phase 3 clinical trials primarily for the treatment of:
- Obesity and chronic weight management.
- Type 2 diabetes.
- Metabolic dysfunction-associated steatotic liver disease (MASLD), also known as fatty liver disease.

Key Benefits (from Clinical Trials)

Phase 2 clinical trials have shown promising, dose-dependent results when used alongside diet and exercise:

Significant Weight Loss: Participants on the highest dose (12 mg) lost up to 24.2% of their body weight over 48 weeks, a result that surpasses current approved medications like Mounjaro and Wegovy in trial comparisons.
Improved Glycemic Control: It has shown clinically meaningful improvements in blood sugar control (HbA1c levels) in patients with type 2 diabetes.
Reduced Liver Fat: High doses led to significant reductions in liver fat content, with many participants achieving normal liver fat levels.

Important Warnings

Availability: Retatrutide is an investigational drug and is not yet approved by the FDA or other regulatory bodies for consumer use.
Safety: Any products sold online as "retatrutide peptide" are unregulated research chemicals and are considered unsafe for human consumption.
Side Effects: The most common side effects reported in trials are primarily gastrointestinal, including nausea, vomiting, diarrhea, and constipation. These are generally mild to moderate and dose-related.